| Trial ID: | L1243 |
| Source ID: | NCT03658876
|
| Associated Drug: |
Iron Sucrose Solution For Injection
|
| Title: |
Predictors of Response to Iron and Erythropoietin Stimulating Agents
|
| Acronym: |
PRIME
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT03658876/results
|
| Conditions: |
Renal Failure Chronic|Anemia
|
| Interventions: |
DRUG: Iron Sucrose Solution for Injection|DRUG: Epoetin Beta
|
| Outcome Measures: |
Primary: Hemoglobin Incrementation, Incrementation of haemoglobin of 5g/l following treatment, Within 2 months |
|
| Sponsor/Collaborators: |
Sponsor: Imperial College London
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
197
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2015-06-03
|
| Completion Date: |
2017-12-31
|
| Results First Posted: |
2019-07-05
|
| Last Update Posted: |
2019-07-05
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03658876
|
